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Pneumonia and Respiratory Distress Syndrome During
Primary Infection with Toxoplasma gondii
SIR- A 26-year-old male acquired human immunodeficiency vi-
rus (HIV) infection through homosexual contact in 1987. He re-
ceived therapy with trimethoprim-sulfamethoxazole (TMP-SMZ;
160/800 mg three times per week) starting in November 1992 and
acquired a kitten in the fall of 1992. Tests for toxoplasmal antibod-
ies (IMX Toxo IgG and IMX Toxo IgM; Abbott Laboratories,
Abbott Park, IL) were negative in January 1991, March 1992,
October 1992, and September 1993.
In October 1993 the patient started complaining of a dry cough.
Serologies for antibody to Toxoplasma gondii were again negative.
He was admitted to the hospital on I December 1993 for fever
(temperature, 40°C), cough, and a bilateral interstitial lung infil-
trate.
Laboratory findings on admission included moderate pancytope-
nia, an elevated level oflactate dehydrogenase (6,450 U/L; normal
range, 187-443 UIL), and an elevated level of creatine kinase
(2,853U/L; normal range, 0-270). The CD4 cell count was 541fJL
A chest roentgenogram showed bilateral reticulonodular infiltrates
with alveolar exudates and mediastinal adenopathies. Auramine-
rhodamine and Ziehl-Neelsen stains of bronchoalveolar lavage
fluid were negative, as were cultures for bacteria and atypical
mycobacteria, but multiple T gondii tachyzoites were seen on
gram staining and acridine orange staining (figure I). Serologic
tests for IgG and IgM antibodies to T gondii were positive.
The patient started receiving therapy with high-dose sulfadiazine
(6 g/d iv) and pyrimethamine (200 mgld followed by 75 mgld iv)
plus prednisone (60 mgld po; dose was tapered over the next 2
weeks) and folinic acid. His condition improved rapidly, and he
was still alive in October 1994; at that time he did not have fever
or pulmonary symptoms and he was receiving 25 mg of pyrimeth-
amine and 2 g of sulfadiazine per day.
Disseminated toxoplasmosis in association with lung involve-
ment and acute respiratory distress syndrome is rare [I]. Examina-
tion of bronchoalveolar fluid after Giemsa or gram staining is
an effective method of diagnosing this condition [2]. Extremely
elevated levels of lactate dehydrogenase, as occurred in our case,
are typical and help to differentiate pulmonary toxoplasmosis from
Pneumocystis carinii pneumonia [3].
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Pulmonary toxoplasmosis usually represents reactivation of qui-
escent parasitic infection after immunosuppression because most
patients have toxoplasmal antibodies before pulmonary symptoms
develop [I]. The course of primary toxoplasmosis in immunosup-
pressed patients is unknown, although case reports of transmission
by transfusion into patients with leukemia have suggested that it
may be life threatening [4].
Our patient had clinical and radiological features that were typi-
cal of toxoplasmal pneumonia. The diagnosis was made by exami-
nation of bronchoalveolar lavage fluid. The strong circumstantial
evidence that our patient had primary toxoplasmal infection is as
follows: he had been exposed to a cat that he had recently acquired,
no IgG antibodies were detected during the 2 years before admis-
sion, and seroconversion occurred (IgG, IgM, and IgA antibodies
were detected) during and after clinical disease.
Although in a few cases described in the literature the patients did
not have toxoplasmal antibodies at the time of diagnosis of toxoplas-
mal pneumonia, it has never been clear whether those patients had a
reactivation of a previous infection or a newly acquired toxoplasmal
infection[I]. Indeed, in the absence of the resultsof previous serologic
tests, it is difficult to assess the presence or absence of latent infection
once immunosuppression is extreme [5].
It is interesting to note that TMP-SMZ (160/800 mg three times
per week) was administered to our patient in the months before
disseminated toxoplasmosis occurred, although we cannot be as-
sured that the patient complied with this regimen. TMP-SMZ is
recognized as efficacious prophylaxis against reactivation of toxo-
plasmosis in patients who are infected with HIV. It is conceivable
that these doses are more likely to fail for immunosuppressed
patients with primary exposure to T gondii.
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Figure 1. Tachyzoites of Toxoplasma
gondii (arrows) in bronchial lavage fluid
from an HlY-infected patient with pneu-
monia and respiratory distress syndrome .
Top. gram stain; bottom, acridine orange
slain (magnification, X600) .
